NxStage Medical, Inc.  

(Public, NASDAQ:NXTM)   Watch this stock  
Find more results for NXTM
+0.02 (0.07%)
Feb 23 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 28.92 - 29.45
52 week 13.49 - 29.99
Open 28.97
Vol / Avg. 0.00/413,208.00
Mkt cap 1.89B
P/E     -
Div/yield     -
EPS -0.09
Shares 64.76M
Beta 0.37
Inst. own 96%
Feb 8, 2017
Q4 2016 NxStage Medical Inc Earnings Release (Estimated)
Nov 29, 2016
NxStage Medical Inc at Piper Jaffray Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin -0.97% -4.84%
Operating margin 0.03% -4.35%
EBITD margin - 4.79%
Return on average assets -1.13% -5.27%
Return on average equity -0.34% -8.03%
Employees 3,600 -
CDP Score - -


350 Merrimack St
LAWRENCE, MA 01843-1748
United States - Map
+1-978-6874700 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


NxStage Medical, Inc. is a medical technology company. The Company is engaged in the development, manufacturing and marketing of products and services for patients suffering from chronic or acute kidney failure. The Company operates through three segments: System One, In-Center and Services. It offers its products and services to various markets, such as home, critical care and in-center. The System One segment is engaged in the sale and rental of the System One and PureFlow SL dialysate preparation equipment, and the sale of disposable products in the home and critical care markets. The In-Center segment is engaged in the sale of blood tubing sets and needles for hemodialysis, primarily for the treatment of end-stage renal disease (ESRD) patients at dialysis clinics, and needles for apheresis. The Services segment offers dialysis services provided to patients at its NxStage Kidney Care dialysis centers.

Officers and directors

Robert G. Funari Independent Chairman of the Board
Age: 68
Bio & Compensation  - Reuters
Joseph E. Turk Jr. President
Age: 48
Bio & Compensation  - Reuters
Jeffrey H. Burbank Chief Executive Officer, Director
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Matthew W. Towse CPA Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
Age: 53
Bio & Compensation  - Reuters
Robert S. Brown President of NxStage Kidney Care
Age: 57
Bio & Compensation  - Reuters
Winifred L. Swan J.D. Senior Vice President, General Counsel
Age: 51
Bio & Compensation  - Reuters
Heyward R. Donigan Director
Age: 54
Bio & Compensation  - Reuters
James J. Peters Director
Bio & Compensation  - Reuters
Daniel A. Giannini CPA, Independent Director
Age: 66
Bio & Compensation  - Reuters
Earl R. Lewis Independent Director
Age: 72
Bio & Compensation  - Reuters